Development and evaluation of a virtual microscopy application for automated assessment of Ki-67 expression in breast cancer

BMC Clinical Pathology

Volumn 11, Issue , 2011, Pages

  Konsti, Juho ^a   Lundin, Mikael ^a   Joensuu, Heikki ^a,b   Lehtimäki, Tiina ^a   Sihto, Harri ^a   Holli, Kaija ^c   Turpeenniemi Hujanen, Taina ^d   Kataja, Vesa ^e,f   Sailas, Liisa ^e   Isola, Jorma ^g   Lundin, Johan ^a,h  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d OULU UNIVERSITY HOSPITAL   (Finland)

^e KUOPIO UNIVERSITY HOSPITAL   (Finland)

^f VAASA CENTRAL HOSPITAL   (Finland)

^g UNIVERSITY OF TAMPERE   (Finland)

^h KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN;

ADULT; ALGORITHM; ANTIGEN EXPRESSION; ARTICLE; AUTOMATION; BREAST CANCER; CANCER SURVIVAL; DISEASE FREE SURVIVAL; HUMAN; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROSCOPY; PROGNOSIS; TISSUE MICROARRAY; VIRTUAL REALITY;

EID: 78951470719     PISSN: 14726890     EISSN: 14726890     Source Type: Journal    
DOI: 10.1186/1472-6890-11-3     Document Type: Article

References (33)

1. Bloom K, Harrington D: Enhanced accuracy and reliability of HER-2/neu immunohistochemical scoring using digital microscopy. Am J Clin Pathol 2004, 121:620-630. (Pubitemid 38533993)
2. Camp RL, Chung GG, Rimm DL: Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat Med 2002, 8:1323-1327. (Pubitemid 35373567)
3. Chen W, Reiss M, Foran DJ: A prototype for unsupervised analysis of tissue microarrays for cancer research and diagnostics. IEEE Trans Inf Technol Biomed 2004, 8:89-96.
4. Chung GG, Zerkowski MP, Ghosh S, Camp RL, Rimm DL: Quantitative analysis of estrogen receptor heterogeneity in breast cancer. Lab Invest 2007, 87:662-669. (Pubitemid 46920099)
5. Corletto V, Verderio P, Giardini R, Cipriani S, Di Palma S, Rilke F: Evaluation of residual cellularity and proliferation on preoperatively treated breast cancer: a comparison between image analysis and light microscopy analysis. Anal Cell Pathol 1998, 16:83-93. (Pubitemid 28218615)
6. Kolles H, Forderer W, Bock R, Feiden W: Combined Ki-67 and Feulgen stain for morphometric determination of the Ki-67 labelling index. Histochemistry 1993, 100:293-296. (Pubitemid 23303682)
7. Layfield LJ, Saria EA, Conlon DH, Kerns BJ: Estrogen and progesterone receptor status determined by the Ventana ES 320 automated immunohistochemical stainer and the CAS 200 image analyzer in 236 early-stage breast carcinomas: prognostic significance. J Surg Oncol 1996, 61:177-184.
8. Lehr HA, Hansen DA, Kussick S, Li M, Hwang H, Krummenauer F, Trouet S, Gown AM: Assessment of proliferative activity in breast cancer: MIB-1 immunohistochemistry versus mitotic figure count. Hum Pathol 1999, 30:1314-1320. (Pubitemid 29534293)
9. Pietilainen T, Lipponen P, Aaltomaa S, Eskelinen M, Kosma VM, Syrjanen K: The important prognostic value of Ki-67 expression as determined by image analysis in breast cancer. J Cancer Res Clin 1996, 122:687-692. (Pubitemid 26349023)
10. Pinder SE, Wencyk P, Sibbering DM, Bell JA, Elston CW, Nicholson R, Robertson JF, Blamey RW, Ellis IO: Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival. Br J Cancer 1995, 71:146-149.
11. Querzoli P, Albonico G, Ferretti S, Rinaldi R, Magri E, Indelli M, Nenci I: MIB-1 proliferative activity in invasive breast cancer measured by image analysis. Journal of Clinical Pathology 1996, 49:926-930. (Pubitemid 26403164)
12. Querzoli P, Ferretti S, Albonico G, Magri E, Scapoli D, Indelli M, Nenci I: Application of Quantitative-Analysis to Biologic Profile Evaluation in Breast-Cancer. Cancer 1995, 76:2510-2517.
13. Stromberg S, Bjorklund MG, Asplund C, Skollermo A, Persson A, Wester K, Kampf C, Nilsson P, Andersson AC, Uhlen M, et al: A high-throughput strategy for protein profiling in cell microarrays using automated image analysis. Proteomics 2007, 7:2142-2150. (Pubitemid 47067200)
14. Sullivan CA, Ghosh S, Ocal IT, Camp RL, Rimm DL, Chung GG: Microvessel area using automated image analysis is reproducible and is associated with prognosis in breast cancer. Hum Pathol 2009, 40:156-165.
15. Turashvili G, Leung S, Turbin D, Montgomery K, Gilks B, West R, Carrier M, Huntsman D, Aparicio S: Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysis. BMC Cancer 2009, 9:165.
16. Turbin DA, Leung S, Cheang MC, Kennecke HA, Montgomery KD, McKinney S, Treaba DO, Boyd N, Goldstein LC, Badve S, et al: Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases. Breast Cancer Res Treat 2008, 110:417-426. (Pubitemid 351962583)
17. Tuominen VJ, Ruotoistenmaki S, Viitanen A, Jumppanen M, Isola J: ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67. Breast Cancer Res 2010, 12:R56.
18. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998, 4:844-847. (Pubitemid 28331029)
19. de Azambuja E, Cardoso F, de Castro G Jr, Colozza M, Mano MS, Durbecq V, Sotiriou C, Larsimont D, Piccart-Gebhart MJ, Paesmans M: Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients. Br J Cancer 2007, 96:1504-1513. (Pubitemid 46762956)
20. Domagala W, Markiewski M, Harezga B, Dukowicz A, Osborn M: Prognostic significance of tumor cell proliferation rate as determined by the MIB-1 antibody in breast carcinoma: its relationship with vimentin and p53 protein. Clin Cancer Res 1996, 2:147-154. (Pubitemid 26046500)
21. Rudolph P, Olsson H, Bonatz G, Ratjen V, Bolte H, Baldetorp B, Ferno M, Parwaresch R, Alm P: Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: Prognostic implications. J Pathol 1999, 187:207-216. (Pubitemid 29037050)
22. Stuart-Harris R, Caldas C, Pinder SE, Pharoah P: Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients. Breast 2008, 17:323-334.
23. Lundin M, Lundin J, Helin H, Isola J: A digital atlas of breast histopathology: an application of web based virtual microscopy. J Clin Pathol 2004, 57:1288-1291. (Pubitemid 39611514)
24. Joensuu H, Lehtimaki T, Holli K, Elomaa L, Turpeenniemi-Hujanen T, Kataja V, Anttila A, Lundin M, Isola J, Lundin J: Risk for distant recurrence of breast cancer detected by mammography screening or other methods. JAMA 2004, 292:1064-1073. (Pubitemid 39129196)
25. Sihto H, Lundin J, Lehtimaki T, Sarlomo-Rikala M, Butzow R, Holli K, Sailas L, Kataja V, Lundin M, Turpeenniemi-Hujanen T, et al: Molecular subtypes of breast cancers detected in mammography screening and outside of screening. Clin Cancer Res 2008, 14:4103-4110.
26. Konsti J, Lundin J, Jumppanen M, Lundin M, Viitanen A, Isola J: A publicdomain image processing tool for automated quantification of fluorescence in situ hybridisation signals. J Clin Pathol 2008, 61:278-282. (Pubitemid 351354229)
27. Ruifrok AC, Johnston DA: Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol 2001, 23:291-299. (Pubitemid 32762920)
28. Cohen J: Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull 1968, 70:213-220.
29. Ahlin C, Aaltonen K, Amini RM, Nevanlinna H, Fjallskog ML, Blomqvist C: Ki67 and cyclin A as prognostic factors in early breast cancer. What are the optimal cut-off values? Histopathology 2007, 51:491-498.
30. Fritz P, Wu X, Tuczek H, Multhaupt H, Schwarzmann P: Quantitation in immunohistochemistry. A research method or a diagnostic tool in surgical pathology? Pathologica 1995, 87:300-309.
31. Sapino A, Marchio C, Senetta R, Castellano I, Macri L, Cassoni P, Ghisolfl G, Cerrato M, D'Ambrosio E, Bussolati G: Routine assessment of prognostic factors in breast cancer using a multicore tissue microarray procedure. Virchows Arch 2006, 449:288-296. (Pubitemid 44367968)
32. Klintman M, Bendahl PO, Grabau D, Lovgren K, Malmstrom P, Ferno M: The prognostic value of Ki67 is dependent on estrogen receptor status and histological grade in premenopausal patients with node-negative breast cancer. Mod Pathol 2010, 23:251-259.
33. Faratian D, Munro A, Twelves C, Bartlett JM: Membranous and cytoplasmic staining of Ki67 is associated with HER2 and ER status in invasive breast carcinoma. Histopathology 2009, 54:254-257.